Skip to main content

Table 2 Intraoperative characteristics stratified by treatment assignment, mean (SD)

From: Factor VIII inhibitor bypass activity (FEIBA) for the reduction of transfusion in cardiac surgery: a randomized, double-blind, placebo-controlled, pilot trial

 

FEIBA

n = 6

Placebo

n = 6

Cardiopulmonary bypass duration, min

276 (111)

170 (53)

Aortic cross-clamp time, min

159 (75)

123 (51)

Lowest temperature during CPB, °C

25 (4)

25 (4)

Deep hypothermic cardiac arrest, n (%)

5 (83)

3 (50)

Deep hypothermic cardiac arrest duration, min

93 (26)

24 (5)

FEIBA study drug dose, IU, mean (SD)

1902 (499)

0

Open-label FEIBA, n (%)

2 (33)

1 (17)

 Dose, IU, mean (SD; n1 = 2; n2 = 1)

3772 (1002)

1840 (--)

 Dose, IU, mean (SD; n1 = 6; n2 = 6)

1241 (2024)

307 (751)

  1. FEIBA, factor eight inhibitor bypass activity; CPB, cardiopulmonary bypass